<VariationArchive VariationID="2422568" VariationName="NC_000023.10:g.(?_133627564)_(133629109_?)del" VariationType="Deletion" Accession="VCV002422568" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1938881" VariationID="2422568">
      <GeneList>
        <Gene Symbol="HPRT1" FullName="hypoxanthine phosphoribosyltransferase 1" GeneID="3251" HGNC_ID="HGNC:5157" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.2-26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460165" stop="134500668" display_start="134460165" display_stop="134500668" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133594174" stop="133634697" display_start="133594174" display_stop="133634697" Strand="+" />
          </Location>
          <OMIM>308000</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_133627564)_(133629109_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="133627564" innerStop="133629109" display_start="133627564" display_stop="133629109" variantLength="1546" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_133627564)_(133629109_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_133627564)_(133629109_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_133627564)_(133629109_?)del AND multiple conditions" Accession="RCV003122163" Version="4">
        <ClassifiedConditionList TraitSetID="10191">
          <ClassifiedCondition DB="MedGen" ID="C0023374">Lesch-Nyhan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268117">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15571220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17027311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19016344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22157001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25136576</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10191" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5397" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lesch-Nyhan syndrome</ElementValue>
                <XRef ID="Lesch+Nyhan+syndrome/4181" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010298" DB="MONDO" />
                <XRef ID="10406007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNS</ElementValue>
                <XRef Type="MIM" ID="300322" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7226" />
                <XRef ID="7226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3039492</ID>
              </Citation>
              <XRef ID="510" DB="Orphanet" />
              <XRef ID="C0023374" DB="MedGen" />
              <XRef ID="MONDO:0010298" DB="MONDO" />
              <XRef Type="MIM" ID="300322" DB="OMIM" />
            </Trait>
            <Trait ID="5209" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HPRT DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="Partial+hypoxanthine-guanine+phosphoribosyltransferase+deficiency/9096" DB="Genetic Alliance" />
                <XRef ID="238007004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOUT, HPRT-RELATED</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16710" />
                <XRef ID="16710" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <XRef ID="79233" DB="Orphanet" />
              <XRef ID="C0268117" DB="MedGen" />
              <XRef ID="MONDO:0010299" DB="MONDO" />
              <XRef Type="MIM" ID="300323" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7071346" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000194.2_X_Partial deletion (exon 6)_133627563_133629109|MedGen:C0023374;C0268117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790847" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15571220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17027311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22157001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19016344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25136576</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 6 (c.429_485+1489delinsA) of the HPRT1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in HPRT1 are known to be pathogenic (PMID: 15571220, 17027311, 22157001). This variant has not been reported in the literature in individuals affected with HPRT1-related conditions. This variant disrupts a region of the HPRT1 protein in which other variant(s) (p.Ala161Thr) have been determined to be pathogenic (PMID: 19016344, 25136576; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPRT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_133627564)_(133629109_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023374" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268117" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7071346" TraitType="Disease" MappingType="XRef" MappingValue="C0268117" MappingRef="MedGen">
        <MedGen CUI="C0268117" Name="Partial hypoxanthine-guanine phosphoribosyltransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071346" TraitType="Disease" MappingType="XRef" MappingValue="C0023374" MappingRef="MedGen">
        <MedGen CUI="C0023374" Name="Lesch-Nyhan syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

